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Cyclosporin A is succesfully used in the treatment of sclero-
derma, a condition with excessive deposition of collagen in 
the dermis. Cultured human dermal fibroblasts were used as a 
model to study the effects of cyclosporin A on metallopro-
teinase expression and activity. Fibroblasts were treated with 
collagenase inducing agents, phorbol 12-myristate 13-ace-
tate (PMA), cytokines interleukin-l beta (IL-1P), tumor ne-
crosis factor alpha (TNFa), and the calcium ionophore 
A23187 in the presence of cyclosporin A under serum-free 
conditions, and alterations in metalloproteinase expression 
were studied by Northern hybridization and immunoblot-
ting analyses, and assays for collagenolytic activity. Induction 
of collagenase expression by PMA and cytokines was en-
hanced severalfold by 1-10 J1M cyclosporin A. Treatment of 
cells with cyclosporin A alone caused only a minor increase in 
collagenase mRNA levels. The secretion of immunoreactive 
C yclosporin A is a widely used immunosuppressive drug used in transplantation medicine and in the treatment of a number of autoimmune disorders. Among the dermatologic disorders treated with this drug are psoriasis and scleroderma [1]. CsA sup-
presses the immune system by inhibiting T-cell activation in an 
early phase [2,3] . The molecular basis of this inhibition has been 
elucidated recently [4-7]. CsA binds to cyclophilins, a ubiquitous 
group of intracellular proteins, that are enzymes with peptidoprolyl 
isomerase activity. CsA: cyclophilin complex is the active effector, 
which acts by binding to calcineurin/protein phosphatase 2B and 
causes a change in its substrate specificity. Thus, the effect of CsA 
seems to be mediated by regulation of serine/threonine phospho-
rylation of phosphoproteins. 
Degradation of extracellular matrix components is an important 
feature of normal physiologic processes such as tissue repair and 
embryonal development. The enzymes responsible for breakdown 
of extracellular matrix components, matrix metalloproteinases 
(MMPs, matrixins), comprise a structurally homologous family of 
proteolytic enzymes with several common properties in secretion, 
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collagenase protein and the level of p-aminophenylmercuric 
acetate activatable collagenase activity were increased by 
PMA and further enhanced by cyclosporin A. The expression 
of the other metalloproteinases stromelysin-1, 92-kD gela-
tinase, and 72-kD gelatinase or metalloproteinase inhibitor 
TIMP-1 were not affected by cyclosporin A. Time depen-
dence analysis of the expression of the mRNAs for c-jull and 
junB indicated that the induction of these genes persisted 
significantly longer in cells treated with both PMA and cy-
closporin A than in cells treated with PMA alone. Enhanced 
induction of collagenase mRNA may thus result from pro-
longed AP-1 activity. The results indicate that cyclosporin A 
potently enhances the expression of collagenase in dermal 
fibroblasts. Key words: metalloproteinase/IL-1/3/PMA/TNFa. 
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activation, and inhibition but different substrate specificities [8]. 
The major components of the extracellular matrix of different con-
nective tissues are collagens, especially the fibrillar collagens of 
types I and III. Breakdown of fibrillar collagens is initiated by inter-
stitial collagenase (MMP-1), a calcium-dependent endoprotease se-
creted as a latent zymogen, which is activated proteolytically in the 
extracellular space. Expression of interstitial collagenase gene is 
stimulated by the phorbol ester PMA and by cytokines, such as 
tumor necrosis factor-a (TNF-a), interleukin-1 (IL-l) and leukore-
gulin [9-12]. Collagenase expression is also stimulated by calcium 
ionophores [13]. 
In the present work we have studied the effects of CsA on metal-
loproteinase expression in cultured human dermal fibroblasts. We 
found that incubation ofPMA and cytokine-treated fibroblasts with 
CsA increased the mRNA levels of collagenase severalfold as shown 
by Northern hybridization analysis. Increase in collagenase mRNA 
levels was preceded by a prolonged induction of the c-jrAn and jllllB 
genes, suggestive of increased AP-l activity. Treatment of cells 
with PMA and CsA resulted also in enhanced secretion of immuno-
reactive collagenase and collagenolytic activity into the conditioned 
medium as compared to cells treated with PMA alone. The immu-
nosuppressive drug CsA has thus an enhancing effect on the expres-
sion of human fibroblast collagenase. 
MATERIALS AND METHODS 
Reagents Phorbol 12-myristate 13-acetate (PMA) , calcium ionophore 
A23187 (calcimycin), cycloheximide, and human type I collagen were pur-
chased from Sigma Chemical Co. (St. Louis, MO). Human recombinant 
IL-1P and TNFa were obtained from Boehringer Mannheim GmbH 
(Mannheim Germany). Cyclosporin A (CsA) was generously provided by 
Sandoz Ltd. (Basel, Switzerland). 
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Cell Cultures and Treatment with Chemicals and Cytokines Nor-
mal human dermaI fibroblasts (PM strain, between passage numbers 8 and 
11 ) [14] , human embryonic lung fibroblasts [CCL-137, American Type 
c ulture Collection (ATCC)] and human dermal fibroblasts from a systemic 
sclerosis patient (CRL-ll08, ATCC) were cultivated in Eagle's minimal 
essential medium containing 10% heat-inactivated feta l bovine serum 
(GIBCO), 100 IU /ml penicillin, and 50 I1g/ml streptomycin. The cultures 
were incubated at 37 · C in a humidified 5% CO2 atmosphere until con-
fluency. Confluent cultures were washed twice with serum-free medium 
and then incubated under serum-free conditions for 16 - 24 h. Subsequently, 
cyclosporin A (0.1-10 11M), PMA (0.4 - 40 nM), interlcukin (IL)-lft (2 
U/mI). tumor necrosis factor a (TN Fa) (30 ng/ml) or the calcium iono-
hore A23187 (300 nM) were added into the medium and the cultures were 
fncubated for 24 h or as indicated . The cultures were then washed with PBS 
(phosphate-buffered saline; 10 mM sodium phosphate, 170 mM sodium 
chloride, pH 7.4) and lysed for RNA extraction. All experiments were 
carried out under serum-free conditions. 
Isolation of RNA and Northern Hybridization Analysis RNA was 
purified by pelleting a guanidium thiocyanate-N-laurylsarcosyl cell lysate 
through a CsCI cushion [15]. Total RNA (15I1g), was electrophoresed on a 
0.8% formaldehyde-agarose gel and transferred to nylon filters (Pall Bio-
dyne, Pall Corporation, East Hills, NY) in 20 X SSC (1 X SSC is 150 mM 
NaCl, 15 mM sodium citrate buffer, pH 7.0). Filters were hybridized to 
probes labeled with [a-32P]dCTP (Amersham International PIC, Amer-
sham, UK) by the random priming method (Boehringer Mannheim 
GmbH). Hybridization was performed in 50 % deionized formamide, 5% 
sodium dodecylsulfate (SOS), 750 mM NaCl, 50 mM NaH 2PO., 5 mM 
ethylenediaminetetraacetic acid (EOTA), 0.02% Ficoll, 0.02% polyvinyl-
pyrrolidone, 0.02% bovine serum albumin at 42·C for 24 h. Subsequent 
washing was carried out in 1 X SSC containing 0.1 % SOS at 60 ·C. Oehybri-
dization, when needed. was performed in 50% deionized formamide. 2 X 
sSC a t 70 ·C for 1 h. The following cONA probes were used: collagenase 
[16]. stromelysin-1 [17]. 72-kO gelatinase [18]. 92-kO gelatinase [19]. 
TIMP-l (ATCC 59667. genomic fragment). glyceraldehyde phosphate de-
hydrogenase (GAPOH) [20],jurlB [21]. C-jllll [22]. and c-fos [23]. 
polyacrylamide Gel Electrophoresis in the Presence ofSDS Polya-
crylamide gel electrophoresis in the presence of SOS (SOS-PAGE) was 
performed according to Laemmli [24], using vertical discontinuous 3.5: 6% 
or 4 - 15% gradient 50S-polyacrylamide gel slabs. The molecular-weight 
markers were phosphorylase b (M, 94.000), bovine serum albumin (M, 
67.000). ovalbumin (M, 43.000), carbonic anhydrase (M, 30,000), and lyso-
zyme (M, 14,300) (Pharmacia LKB. Uppsala, Sweden). 
ItnIDunoblotting Assay for Collagenase For the immunoblotting 
analysis. confluent cultures of fibroblasts were treated with PMA (1 nM) and 
CsA (10 11M) under serum-free conditions. After 8 h incubation the condi-
tioned medium was replaced with fresh medium containing PMA and CsA 
as indicated, and incubation was continued for 24 h. An aliquot of condi-
tioned medium (10 Jll) was dissolved in Laemmli sample buffer and subjected 
to 4 - 15% gradient SOS-PAGE under non-reducing conditions. Proteins 
were electrophoretic ally transferred to polyvinylidene difluoride mem-
branes (Immobilon P, Millipore Corporation, Bedford. MA) at 100 rnA for 2 
h. Membranes were saturated with 5% milk in PBS/Triton X-I00 (0.5%) 
and incubated with polyclonal rabbit antiserum against human fibroblast 
collagenase (kindly provided by Or. H. Birkedahl-Hansen. University of 
Alabama. Birmingham. AL) (1: 2000 dilution) in 100 mM Tris-HCl buffer. 
pH 8.5, containing 1 M NaCI. 0.2% bovine serum albumin (BSA), and 0.2% 
Tween-20. After several washes with the same buffer the bound antibodies 
were detected using peroxidase-conjugated antirabbit-immunoglobulins 
(Dakopatts. Copenhagen. Oenmark) and enhanced chenilluminescence 
Western blotting detection system (Amersham International PIC, Amer-
sham, UK) as described [25] . 
Assay for Collagenolytic Activity Collagenolytic activity of the condi-
tioned medium was measured essentially as described (26). Human placental 
type I collagen (Sigma) was dissolved in 10 mM acetic acid. dia lyzed against 
50 rnM Tris-Hel buffer. pH 7.5. containing 10 mM CaCl2, and concen-
trated using Centricon 10 microconcentrators (final concentration 0.3 mg/ 
ml) (Amicon Inc., Beverly. MA). Fibroblasts were treated with PMA (lnM) 
and CsA (10 11M) under serum free conditions. After 8 h incubation the 
conditioned medium was replaced with fresh medium containing PMA and 
CsA, and the incubation was continued for 24 h. Subsequently. the condi-
tioned medium was collected and concentrated thirtyfold as above. Human 
type I collagen (5 Jlg/lane) was incubated with an aliquot (25 Ill) of the 
conditioned medium concentrate at 25·C for 6 d. Where indicated. p-amin-
ophenylmercuric acetate (final concentration 1 mM) was added to the me-
dium samples to activate latent collagenase [27]. The proteins were then 
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dissolved in Laemmli gel sample buffer containing 10% 2-mercaptoethanol. 
separated by 6% SOS-PAGE and visualized by Coomasie brillia.nt blue 
G-250 staining. 
RESULTS 
Induction of Collagenase Gene Expression by PMA, TNFa, 
IL-1P, or Calcium Ionophore A23187 Is Enhanced by Cyclo-
sporin A To analyze the effect of CsA on collagenase production 
itl vitro we incubated human dermal fibrobl asts with C sA under 
serum-free conditions. Because human dermal fibroblasts produce 
very low amounts of collagenase under these conditions, we used 
PMA, an activator of protein kinase C, cytokines IL-IP. and TNFa, 
and the calcium ionophore A23187 to induce collagenase gene ex-
pression. The cells were treated with CsA. PMA and cytokines and 
at the termination of incubation lysed and analyzed for the expres-
sion of collagenase mRNA by Northern hybridization analysis . In 
accordance with earlier results, treatment of cells with PMA (40 
nM) alone for 24 h markedly induced collagenase mRNA levels 
(Fig lA) [9]. The exposure of cells to CsA (10 liM) together with 
PMA enhanced collagenase mRNA levels further about fivefold 
(Fig lA). Incubation of cells with CsA alone had a minor effect that 
could be detected only in very long exposures of the film (Fig IB) . 
The levels of stromelysin-l and tissue inhibitor of metalloprotein-
ases (TIMP-l) mRNAs were enhanced by PMA. but they were not 
affected by CsA. The basal level of the 92-kD gelatinase expression 
was very low in these cells. However. the eXfression of 92-kD 
gelatinase could be enhanced to a detectable leve by PMA, but CsA 
did not have any effect on 92-kD gelatinase mRNA levels (data 
not shown). Neither PMA nor CsA h ad any effect on the expres-
sion of 72-kD gelatinase (Fig lA). As noted previously, TNFa, 
IL-lP, or A23187 induced collagenase mRNA levels in dermal fi-
broblasts. When cells were treated simultaneously with CsA and 
either TNFa, IL-lP or A23187. enhanced induction of collagenase 
gene expression was observed, although the level of collagenase 
expression remained lower than that noted with PMA treatment 
(Fig Ie). 
We analyzed next the effect of CsA on collagenase expression of 
two other fibroblast strains. Confluent cultures of human embry-
onic lung fibrob lasts (CCL-137) and dermal fibroblasts from a 
systemic sclerosis patient (CRL-ll08) were treated with PMA 
and CsA as above, and analyzed for the expression of collagen-
ase mRNA. The basal expression level of collagenase was low in 
both cell lines and it was remarkably enhanced by PMA. CsA en-
hanced the collagenase mRNA levels slightly in lung fibroblasts 
and more efficiently in scleroderma fibroblasts (Fig 2) . Treatment 
of the scleroderma fibroblasts with CsA aIone increased the level 
of collagenase mRNA to a detectable level, whereas in lung fibro-
blasts collagenase mRNA levels remained undetectable (data not 
shown). 
Collagenase Induction Is Dependent on both PMA and CsA 
Concentrations Protein kinase C is down regulated at high 
PMA concentrations after prolonged treatment of cells [28]. Conse-
quently, our observations of the effect of CsA at a high PMA con-
centration (40 nM) could be explained by inhibition of down-
regulation of cell membrane bound active PKC by CsA. The 
concentration dependence of CsA effect on collagenase mRNA 
levels was studied by treating cells with various concentrations of 
CsA and PMA. Subsequent Northern hybridization analysis indi-
cated that the expression of collagenase mRNA was barely detected 
at 0.4 nM PMA (Fig 3A) . However, under low PMA (0.4 nM) 
concentrations the enhancing effect of CsA w as even more promi-
nent than at a high PMA concentration. Even at as high as 40 nM 
PMA concentration the effect of CsA was essentiaIly the same sug-
gesting that CsA does not act by inhibiting the down regulation of 
protein kinase C. In a subsequent experiment the cells were treated 
with increasing concentrations of CsA ranging from 0 .1 to 10 liM in 
the presence of PMA. A marked enhancement of PMA effect on 
collagenase mRNA levels was noted with IllM CsA, and 10,l1M 
CsA gave even a more prominent effect (Fig 3B). 
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Figure 1. Cyclosporin A enhances the induction of collagenase mRNA by PMA. cytokines and calcium ionophore A23187 in human dermal fibroblasts. 
Confluent cultures of fibroblasts were treated with PMA (40 nM), TNFa (30 ng/ml). IL-1P (2 U Iml), or the calcium ionophore A23187 (300 nM) together 
with CsA (10 JLM) under serum free conditions for 24 h as indicated on the figure (see Materials alld Methods for details) . Total RNA was then isolated and 
analyzed by Northern hybridization using the indicated probes. The amounts of mRNA were controlled using GAPDH as an internal standard. Autoradio-
grams of Northern hybridization analyses of total RNA (15 JLg) are shown. A: Regulation of the mRN A levels of collagenase, other metalloproteinases, and 
TIMP-1 by PMA and CsA. The designations of the probes are indicated on the left. B: The collagenase blot of A was exposed for 7 d instead of 1 d (shown in A) 
to detect the basal level of collagenase mRNA in untreated cells. An enhancement of collagenase expression by CsA alone was detected. C: Induction of 
collagenase by TNFa, IL-1P, and calcium ionophore A23187; enhancement by CsA. 
Enhancement of Collagenase Gene Induction by CsA Is De-
pendent of Protein Synthesis To examine whether the en-
hancement of collagenase gene induction by CsA requires protein 
synthesis, fibroblasts were incubated with cycloheximide (10 ).lgl 
ml) for 1 h before CsA (10 ).lM) and PMA (40 nM) were added. The 
cells were then incubated for 24 h, and collagenase mRNA levels 
were analyzed. The results show that cycloheximide efficiently 
prevented both the induction of collagenase mRNA by PMA and 
the enhancing effect of CsA, suggesting that protein synthesis is 
needed for the CsA effect (Fig 4) . However, cycloheximide alone 
enhanced collagenase expression approximately threefold when 
compared to the very low basal collagenase mRNA level of un-
treated control cells, detected only after very long exposures of the 
Northern blot (data not shown). 
Treatment of Fibroblasts with PMA and CsA Leads to a Pro-
longed Induction of jun Genes The filter from the cyclohexi-
mide experiment was also hybridized with cDNA probes specific 
for c-jun and junB. In this experiment, an induction of c-jun and 
jun-B mRNAs by CsA could be detected after a 24-h incubation (Fig 
4). Simultaneous treatment of the cells with cycloheximide en-
hanced the expression of c-jull and jutlB mRNAs several fold. On 
the other hand, PMA seemed to reduce the mRNA levels of c-jull 
and jutlB after prolonged treatment (24 h) with high concentration 
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Figure 2. CsA enhances collagenase mRNA expression in human lung fibroblasts and in dermal fibroblasts from a systemic sclerosis patient. Confluent 
cultures of embryonic human lung fibroblasts (CCL-137) and dermal fibroblasts from a systemic sclerosis patient (CRL-I108) were treated with PMA (40 nM) 
together with CsA (10 )lM) under serum-free conditions for 24 h. Total RNA was then isolated and analyzed by Northern hybridization using the collagenase 
eDNA probe. Autoradiograms of Northern hybridization ana lyses of total RNA (15 )lg) are shown. Note the prominent enhancement in CRL-II08 cells. 
ofPMA (40 nM) (Fig 4, lower panel), possibly because of the down-
regulation of protein kinase C. 
To compare the effects ofPMA and CsA on the time course of the 
eJCpression of mRNAs for collagenase, and the early response genes 
c-Jos, c-jrw and junB, fibroblasts were treated with PMA and CsA, 
follow-ed by Northern hybridization analysis. Expression of colla-
genase mRNA was detectable at 8 h of incubation and it was en-
hanced at 24 h (Fig 5). At both of these time points collagenase 
mRN A levels were markedly enhanced by CsA. The induction of 
® CsA (10 J-lM) 
i i 
PMA (nM): 0.4 4 40 0.4 4 
collagenase 
GAPDH 
® PMA (0.4 nM) 
CsA (flM): 0.1 1 10 
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Figure 3. CsA-mediated enhancement of collagenase mRNA induction 
depends on both PMA and CsA concentrations. Confluent cultures of 
human dermal fibroblasts were treated with various concentrations ofPMA 
and CsA for 24 h as indicated. Northern hybridization analysis of total RNA 
(15 ,ug) was carried out using the collagenase eDNA probe. A : Dependence 
on PMA concentration. B: Dependence on CsA concentration. 
collagenase mRNA was preceded by an induction of the c-jrm and 
junB genes. Cells treated with both PMA and CsA expressed c-jrlll 
mRNA substantially longer (at least 24 h) than cells treated with 
PMA alone (8 h) . Slightly more persistent expression of jlmB was 
also noted with PMA and CsA treated cells, althoughjllnB mRNA 
levels returned to initial levels by 24 h. A transient induction of the 
c-fos gene was observed at t h and 1 h time points in both treatment 
groups (data not shown) . 
Treatment of Cells with PMA and CsA Leads to Enhanced 
Collagenase Secretion and Activity To study the effect of CsA 
on collagenase secretion, fibroblasts were treated with PMA (111M) 
and CsA (10 ,uM) for 32 h, and the conditioned medium was col-
lected and assayed by immunoblotting using polyclonal antibodies 
to collagenase (see Materia ls a/ld Methods). The conditioned medium 
of untreated cells did not contain detectable levels of immunoreac-
tive collagenase (Fig 6A) . Cells treated with PMA secreted colla-
genase into their conditioned medium (a closely spaced doublet of a 
faint 56-kD and strong 52-kD band were seen in the immunoblot). 
Treatment of the cells with both PMA and CsA led to an approxi-
mately fourfold increase in the amount of secreted collagenase as 
estimated by the immunoblot (Fig 6A). 
To assess the effect of PMA and CsA on the collagenase activity 
secreted by fibroblasts, conditioned medium from the experiment 
described above was concentrated thirtyfold. Collagenolytic activ-
ity was assayed by incubating the conditioned medium with purified 
type I collagen, and measuring the accumulation of degradation 
products specific for collagenase by SDS-PAGE (see Materials and 
Methods) . The conditioned medium of untreated fibroblast cultures 
did not contain active or APMA-activatable collagenase. Cells 
treated with PMA produced latent, APMA-activatable collagenoly-
tic activity into their conditioned medium (Fig 6B). Accordingly, 
treatment of the cells with both PMA and CsA resulted in a signifi-
cant increase in the level of secreted latent collagenolytic activity, 
which resulted in enhanced degradation of the type I collagen sub-
strate after activation by APMA. Treatment of the cells with CsA 
alone did not have any detectable effect on the secreted collagenoly-
tic activity. 
DISCUSSION 
Cyclosporin A is used widely as an immunosuppressive drug in a 
number of autoimmune conditions [1]. One of these is scleroderma 
in which initial dermal perivascular inflammatory reaction results 
in excessive deposition of extracel lular matrix, especially collagen 
in the dermis [29,30]. A number of clinical studies have shown that 
CsA has a beneficial effect both in systemic and localized sclero-
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Figure 4. Effect of CsA on collagenase mRNA expression involves protein synthesis-relationships to the jutlB and c-jutl genes. Fibroblasts were treated with 
PMA, CsA, and the protein synthesis inhibitor cycloheximide (CHX) for 24 h as indicated. Northern hybridization analysis of total RNA (15Ilg) was carned 
out using the collagenase probe (top) . Bottolll: the same filter was analyzed by jutlB and C-jIHl probes. Note that the signals on the left (cells not treated With 
CHX) were much weaker, necessitating an exposure time of 6 d instead of 1 d, as on the right. 
derma [1,29,31,32] . This antifibrotic effect of CsA appears to be in 
part due to suppression of the early inflammatory reaction in sclero-
derma, because CsA decreases the expression ofIL-2 and IFNy [2,3] . 
This results indirectly in the decreased production of IL-1 and 
TNFa in T-cells and monocytejmacrophages. The decrease of 
PMA 
these collagenase inducing stimuli by CsA may contribute to an 
inhibition of the degradation of deposited collagen. 
In the present study we found that unstimulated human fibro-
blasts express very low basal levels of collagenase gene . Collagenase 
mRNA was markedly increased by PMA, as well as by the cytokines 
PMA + CsA 
r-----------------------------------------" r'----------------------------------------~ 
Time (h): o 0.5 1 3 8 24 o 0.5 1 3 8 24 
collagenase 
c-jun 
junB 
GAPDH 
Figure 5. Time dependence of PMA and CsA on collagenase and transcription factor mRNA expression. Fibroblasts were treated with PMA and CsA as 
indicated. At times shown the cells were lysed, and total RNA was isolated and analyzed by Northern hybridization using the probes indicated. Note the 
persistence of c-jun and jlmB in the lanes PMA + CsA. 
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Figure 6. Cyclosporin A enhances the secretion of immunoreactive colla-
genase and collagenase activity in cultured fibroblasts. Confluent cultures of 
human dermal fibroblasts were treated with PMA (1 nM) and CsA (10 ItM) 
under serum-free conditions for 36 h (see Materials and Methods) as shown. 
conditioned medium was then collected and analyzed as follows. A : Im-
rnunoblotting analysis for secreted amounts of collagenase. Aliquots of con-
ditioned medium (10 Itl) were dissolved in Laemmli gel sample buffer and 
subjected to 4-15% gradient SOS-PAGE under non-reducing conditions. 
The proteins were then electrophoretically transferred to PVOF membrane 
and immunostained with polyclonal collagenase antiserum. The position of 
collagenase is indicated. B: Analysis of collagenase activity. Conditioned 
medium was concentrated thirtyfold. Human type I collagen (5 ltg/lane) 
was incubated for 6 d at 25°C with the conditioned medium concentrate. 
Latent collagenase was activated by p-aminophenylmercuric acetate 
(APMA) where in~icated. 'The proteins were ~hen separated by 6% SOS-
PAGE under reducmg conditIOns and stamed With CoomaSSIe blue. Lalle C: 
untreated collagen. Type 1 collagen chains are indicated by (X, (I) and cx2(1), 
and the cleavage products by arrows. The migration of molecular weight 
markers (X 10-3) are shown on the left. 
IL-IP and TNFa. and calcium ionophore A23187. CsA alone had a 
minor but detectable enhancing effect on collagenase expression. 
However. in the cells treated with PMA or other inducers of colla-
genase. CsA enhanced significantly collagenase mRNA levels. In-
creased collagenase mRNA abundance resulted in enhanced colla-
genase secretion as seen by immunoblotting of the conditioned 
medium, and in increased levels of latent, APMA-activatable colla-
genolytic activity in the conditioned medium. CsA could also en-
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hance the induction of collagenase by PMA in human embryonal 
lung fibroblasts and dermal fibroblasts from a patient with systemic 
sclerosis. 
One of the side effects of CsA treatment is gingival hyperplasia 
[33]. In the study of Tipton et ai, different human gingival fibroblast 
strains CsA had divergent effects on the production of collagenase 
activity [34]. In most fibroblast strains collagenase activity decreased 
but in some strains it was enhanced. However, the assay conditions 
differ from those of the present work in many respects. Tipton et al 
incubated their gingival fibroblast cultures with rather low concen-
trations of CsA (0.09-0.7 11M) for up to 8 d. and analyzed the 
collagenase secretion by enzyme-linked immunosorbent assays and 
activity measurements. On the other hand. CsA appears to stimulate 
proliferation and collagen synthesis by gingival fibroblasts [35] . It 
has also been found that CsA slows triple helix formation of type I 
collagen resulting in reduction of type I collagen production by 
cultured fibroblasts [36]-
Previously it has been shown that the induction of collagenase by 
PMA as well as by the cytokines IL-1/3 and TNFa is in part mediated 
by AP-1, a dimeric transcription factor complex consisting of Jun 
and Fos proteins [8 -10]. Treatment of cells with PMA leads to a 
transient induction of clos and to a slighty longer lasting induction 
of c-jurl resulting in enhanced AP-1 activity [37]. The transcrip-
tional activity ofJun proteins is controlled by complex mechanisms 
including regulation of phosphorylation of certain residues, forma-
tion of homo- and heterodimers with various members of Jun and 
Fos families, and regulation of the stability of these dimers. It has 
recently been reported that the members ofJun family also contrib-
ute to a transcriptional activity with properties distinct from AP-1 
activity by a calcium-regulated CsA sensitive pathway [38]. Our 
time-dependence analysis indicated that treatment of cells with 
PMA alone resulted in a rapid and transient induction of c-jUtl and 
junB mRNA levels. Interestingly, combination of CsA with PMA 
resulted in a persistent induction of c-jull: the mRNA levels re-
mained elevated at 24 h. CsA also prolonged the induction of the 
junB gene, which could be seen still after 8 h of incubation with 
CsA. This might lead to the persistence of high level AP-1 activity, 
which could explain the increased collagenase mRNA levels. 
Induction of c-jlll! gene is at least partially mediated by AP-1 
consisting of c-Fos and preformed Jun proteins. Jun protein is capa-
ble of binding to AP-1 site only in a de phosphorylated form, where 
ser-243 and ser-249 and thr-239 are in a dephosphorylated state (see 
[39]). Furthermore, c-Fos that is complexed with dephosphorylated 
c-Jun has a longer half-life than c-Fos that is dimerized with phos-
phorylated forms of c-Jun [40]. It is not known whether this de-
phospho.rylation is due to the inhibition of some protein kinase or 
activation of a protein phosphatase. As a serine/threonine specific 
protein phosphatase, calcineurin (PP2B) might dephosphorylate 
Jun protein at these sites. and modulation of the substrate specificity 
of calcineurin by CsA could enhance this dephosphorylation event. 
On the other hand, phosphorylation ofN-terminal serine/threon-
ine residues is required for full transactivation capability ofJun-pro-
tein. In this context, it is interesting to note that collagenase can be 
induced also by okadaic acid, an inhibitor of protein phosphatase 
2A. Treatment of cells with okadaic acid results in slightly increased 
expression of c-jlln and a prolonged induction of clos lasting at least 
48 h, which leads to an increased AP-1 activity [41]. 
Two other metalloproteinases, stromelysin-1 and 92-kD gelatin-
ase and the metalloproteinase inhibitor TIMP-1 are strongly in-
duced by PMA [19, 42]. The induction of these proteins is also at 
least partially mediated by AP-1 transcription factor. However, CsA 
had no enhancing effect on their mRNA levels. This suggests that 
the effects of CsA are not entirely mediated by AP-1. Another 
metalloproteinase, 72-kD gelatinase. is not regulated by PMA [19, 
43], and CsA did not have any effect on its expression. 
The results of this study suggest that CsA treatment results in 
enhanced turnover of the fibrotic extracellular matrix by increasing 
matrix degradation. The induction and enhancement of collagenase 
expression by CsA is probably of therapeutic relevance. The con-
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centrations of CsA used in these experiments may be achieved at 
certain sites in vivo under standard cyclosporin therapy. It is con-
ceivable that treatment of scleroderma with CsA would be espe-
cially beneficial when combined to extracorporeal pl~otopheresis, 
which is both immunosuppressive and induces expresslOn of TN Fa 
by monocytes [44,45]. In addition to inducing collagenase g~ne 
expression, TNFa also suppresses type I collagen gene expreSSlOn 
by fibroblasts [9,46]. Thus CsA may offer a .novel appro~ch to the 
treatment of fibrosis by enhancmg degradation of fibrotic connec-
tive tissue. 
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